Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590M
-
Number of holders
-
1305
-
Total 13F shares, excl. options
-
515M
-
Shares change
-
-2.24M
-
Total reported value, excl. options
-
$66.6B
-
Value change
-
-$187M
-
Put/Call ratio
-
0.99
-
Number of buys
-
563
-
Number of sells
-
-510
-
Price
-
$129.55
Significant Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q4 2021
1,446 filings reported holding EW - Edwards Lifesciences Corp - Common Stock as of Q4 2021.
Edwards Lifesciences Corp - Common Stock (EW) has 1,305 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 515M shares
of 590M outstanding shares and own 87.2% of the company stock.
Largest 10 shareholders include BlackRock Inc. (57M shares), VANGUARD GROUP INC (49.1M shares), STATE STREET CORP (26.9M shares), Bank of New York Mellon Corp (22.2M shares), Capital International Investors (21.9M shares), BROWN ADVISORY INC (16.7M shares), WELLINGTON MANAGEMENT GROUP LLP (15.6M shares), ALLIANCEBERNSTEIN L.P. (13.4M shares), SANDS CAPITAL MANAGEMENT, LLC (12.7M shares), and GEODE CAPITAL MANAGEMENT, LLC (11.1M shares).
This table shows the top 1305 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.